TARBP2 and hepatocellular carcinoma: Specifically, TARBP2 in white blood cells showed a good capacity for distinguishing HCC patients from healthy controls (area under curve [AUC] = 81.5%; 95% confidence interval [CI], 75.0%-88.0%) with a sensitivity of 0.90 and a specificity of 0.59 at the cut-off of 0.14 (Figure 1F).